216 related articles for article (PubMed ID: 15732048)
21. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
22. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
[TBL] [Abstract][Full Text] [Related]
23. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
[TBL] [Abstract][Full Text] [Related]
24. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution.
Qunibi WY; Barri Y; Alfurayh O; Almeshari K; Khan B; Taher S; Sheth K
Transplant Proc; 1993 Feb; 25(1 Pt 2):1402-5. PubMed ID: 8442155
[No Abstract] [Full Text] [Related]
26. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
27. Conversion to sirolimus in posttransplant renal neoplasms.
Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M
Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158
[TBL] [Abstract][Full Text] [Related]
28. [Kaposi's sarcoma in patients with kidney transplantation].
Vlasić-Matas J; Rumboldt Z; Puizina-Ivić N; Luksić B; Milas I; Dubravcić M; Forempoher G
Lijec Vjesn; 1994; 116(3-4):95-7. PubMed ID: 8057746
[TBL] [Abstract][Full Text] [Related]
29. Incidence of cancer after kidney transplant: results from the North Italy transplant program.
Pedotti P; Cardillo M; Rossini G; Arcuri V; Boschiero L; Caldara R; Cannella G; Dissegna D; Gotti E; Marchini F; Maresca MC; Montagnino G; Montanaro D; Rigotti P; Sandrini S; Taioli E; Scalamogna M
Transplantation; 2003 Nov; 76(10):1448-51. PubMed ID: 14657684
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
[TBL] [Abstract][Full Text] [Related]
31. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
32. Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia.
Fernández A; Marcén R; Pascual J; Galeano C; Ocaña J; Arellano EM; Alfaro C; Villafruela JJ; Burgos FJ; Ortuño J
Transplant Proc; 2006 Oct; 38(8):2453-5. PubMed ID: 17097965
[TBL] [Abstract][Full Text] [Related]
33. [Risk factors and development of skin neoplasms in patients after kidney transplantation].
Sułowicz J; Krzanowski M; Wojas-Pelc A
Przegl Lek; 2005; 62(7):698-702. PubMed ID: 16463705
[TBL] [Abstract][Full Text] [Related]
34. De novo cancer occurrence after renal transplantation: a medical center experience in Taiwan.
Chiang YJ; Chen CH; Wu CT; Chu SH; Chen Y; Liu KL; Chen SW; Chuang CK
Transplant Proc; 2004 Sep; 36(7):2150-1. PubMed ID: 15518780
[TBL] [Abstract][Full Text] [Related]
35. [Solid tumors after kidney transplantation].
Moal MC
Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
[TBL] [Abstract][Full Text] [Related]
36. Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
Kaposztas Z; Etheridge WB; Kahan BD
Transplant Proc; 2008 Jun; 40(5):1744-6. PubMed ID: 18589184
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant lymphoproliferative disorder.
Everly MJ; Bloom RD; Tsai DE; Trofe J
Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous Hodgkin's disease and Kaposi sarcoma in a renal transplant recipient.
Yaich S; Zagdane S; Charfeddine K; Hssairi D; Hachicha J
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):306-9. PubMed ID: 20228518
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment.
Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954
[TBL] [Abstract][Full Text] [Related]
40. [Malignant tumors following renal transplantation].
Végso G; Járay J
Orv Hetil; 2007 Nov; 148(45):2115-23. PubMed ID: 17984022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
